|
|
|
|
|
|
 
|
Biomarkers in Clinical Trials |
|
20th & 21st September 2010 |
|
SMi’s
Biomarkers in Clinical
Trials conference
will present attendees with new concepts in
biomarker application as well as a comprehensive
review of recent developments. This unique event
will bring together academics and industry
professionals in order to provide a complete
picture. There will be a strong focus on using
biomarkers to bridge the gap between basic and
applied research in drug development.
|
|
|
|
|
|
Biosimilars &
Biobetters |
|
22nd
& 23rd September 2010 |
Drawing on the strength of
SMi's successful Generics, Supergenerics and Patent
Strategies series, we are proud to present our
inaugural Biosimilars & Biobetters conference taking
place on the 22nd
& 23rd
September 2010 in
London, UK. Book
before the 28th
May to save £300 on your place.
|
|
|
|
|
|
KOL: Knowledge
Leader Partnerships |
|
29th
& 30th September 2010 |
|
This
September, SMi offers the latest conference in
its highly regarded series on KOL management –
KOL: Knowledge
Leader Partnerships.
Featuring presentations and panel debates from
the key players in the industry, alongside views
from agencies and the media, this conference is
a must-attend event to discover how best to
direct your Opinion Leader programme.
|
|
|
|
|
|
|
|
Managing
Partnerships with CROs |
|
4th
& 5th
October 2010 |
The CRO
industry is growing fast, with an annual growth
rate of over 8.5% and is expected to reach
US$35bn by 2015. Driven in part by the intense
pressures of the global economic environment,
shrinking product pipelines, generic competition
and rapidly increasing costs, the pharmaceutical
and biotech industries are turning to CROs in
order to reduce risk/costs, increase
efficiencies and remain competitive. However,
managing partnerships with external
organisations presents many challenges and
opportunities.
|
|
|
|
|
|
Point of Care Diagnostics |
|
25th
& 26th
October 2010 |
Point-of-care testing is
forecast to expand from US$13.4 billion in 2008 to
over US$22.5 billion in 2013 and comprise 25% of the
total in vitro diagnostics market. Growth has been
driven in part due to the promise of speed,
convenience, and improved patient outcomes that
point of care testing can bring.
|
|
|
|
|
|
Emerging
Therapeutic Strategies for Metabolic Disorders |
|
10th
& 11th
November
2010 |
SMi's annual
conference on Emerging Therapeutic Strategies
for Metabolic Disorders will approach the
subject of metabolic disorders and
metabolic syndrome from many different
angles. The therapeutic
application of metabolic inhibitors,
pharmacotherapy for obesity, immune therapy in type 1 diabetes and receptor agonists are just some of the topics being covered.
Speakers will include industry leaders and
academic experts from prominent organisations
and renowned universities throughout Europe.
|
|
|
|
|
|
Personalised Medicine |
|
11th
& 12th
November 2010 |
As a
concept, personalised medicine has the potential to
revolutionise healthcare and to massively improve
patient outcomes. Attend SMi’s 2010
Personalised Medicine conference to study the latest
developments in the science and the latest business
strategies and partnership models moving the
industry nearer to a personalised future.
|
|
|
|
|
|
Clinical Trials in CNS |
|
15th
& 16th
November
2010 |
This years' conference
on Clinical Trials in CNS,
is taking place on the 15th and 16th
November 2010 in London,
and will bring together leading industry experts to
explore the current and future opportunities within
CNS drug development.
|
|
|
 |
|
COPD: Novel
Therapeutics and Management Strategies |
|
17th
& 18th
November 2010 |
This year, SMi offers its
2nd annual conference
COPD: Novel Therapeutics and Management
Strategies.
In the Western world, COPD
is the only major cause of death that is on the
increase – despite this, COPD tends to be
neglected in terms of drug discovery and
development when compared to Asthma.
|
|
|
|
|
|
Cell Based Assays |
|
22nd
& 23th
November 2010 |
Now that the majority of
screening assays employ the use of cell-based
technologies, robust cell-based assays are essential
for lead identification and the optimisation of
therapeutic candidates. Join SMi at their 3rd annual
Cell-Based Assays
conference where they will assemble leading experts
from both industry and
academia to present you
with the latest
techniques, technologies and critical strategies
in a practical, case study focused environment.
|
|
|
|
|
|
Pharmaceutical
Cold Chain
Distribution |
|
1st
& 2nd
December 2010 |
The UK’s leading
conference on Cold
Chain Distribution is
due to take place on the
1st
and 2nd
December 2010 in
London, and brings
together leading industry experts to share and
discuss the latest developments in the field, as
well as relating personal experiences and
professional case studies.
|
|
|
|
|
|
|
|
I
back
I
top
I |
|
All rights reserved